Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Panel for Arena Obesity Drug
Yahoo/Zacks.com
Thursday, June 3, 2010 - 8:54pm
tags:
Arena Pharmaceuticals, obesity, FDA, advisory panels
Abbott Laboratories gets FDA approval for Architect HE4 blood test for ovarian cancer
Yahoo/AP
Thursday, June 3, 2010 - 8:48pm
tags:
Abbott Laboratories, FDA, ovarian cancer, Architect HE4
FDA panel rejects AZ's new RSV drug in key setback
Fierce Biotech
Thursday, June 3, 2010 - 10:07am
tags:
RSV, motavizumab, MedImmune, FDA, AstraZeneca
Immunocellular brain cancer vaccine shows promise
Reuters
Thursday, June 3, 2010 - 10:05am
tags:
vaccines, ImmunoCellular, brain cancer
Congressional probe into J&J plant expands to include questions about PediaCare recall
Yahoo/AP
Thursday, June 3, 2010 - 10:04am
tags:
JNJ, congress, recalls, PediaCare
Javelin sues Hospira over stalled merger
Marketwatch
Thursday, June 3, 2010 - 10:03am
tags:
Javelin, M&A, Hospira, lawsuits
Merck Launches Global Trial Network For Cancer-Drug Creation
WSJ Online
Thursday, June 3, 2010 - 9:55am
tags:
Merck, innovation, R&D, cancer
Sleepwalking: Cephalon Takes A Hit On Nuvigil
Pharmalot
Thursday, June 3, 2010 - 9:52am
tags:
NUVIGIL, Cephalon
Glaxo’s Avandia Helps Prevent Diabetes in Low-Dose Combination
Bloomberg
Thursday, June 3, 2010 - 9:50am
tags:
GSK, Avandia, diabetes, metformin
Pharma Job Cuts Exceed 34,000 This Year
Pharmalot
Thursday, June 3, 2010 - 9:49am
tags:
layoffs
Another View: Can Biotech Survive Icahn?
NY Times, NY
Thursday, June 3, 2010 - 9:48am
tags:
biotech, Carl Icahn, Genzyme
Elan CEO Kelly Martin to Step Down in 2012
WSJ Online
Thursday, June 3, 2010 - 9:44am
tags:
Elan, Kelly Martin, Pharma CEOs
Two Biotechs With Promising Charts
TheStreet.com
Thursday, June 3, 2010 - 9:43am
tags:
Ariad Pharmaceuticals, Achillion
Novartis's Afinitor meets Phase III trial endpoint
Marketwatch
Thursday, June 3, 2010 - 9:41am
tags:
Novartis, Afinitor, clinical trials, pancreatic cancer
FDA orders new warning labels on GlaxoSmithKline asthma drugs Serevent, Advair
Bizjournals.com
Thursday, June 3, 2010 - 9:23am
tags:
warnings, Serevent, GSK, FDA, asthma, Advair
Life Technologies Spending $100 Million In Synthetic Biology
Forbes
Wednesday, June 2, 2010 - 6:05pm
tags:
Life Technologies, M&A, Synthetic Genomics, GEneart, synthetic biology
Teva gets FDA approval for generic acne treatment
Yahoo/AP
Wednesday, June 2, 2010 - 6:02pm
tags:
Teva Pharmaceuticals, generics, FDA, acne, Galderma, Differin
Four Scenarios For Bristol-Myers
Forbes
Wednesday, June 2, 2010 - 6:00pm
tags:
Bristol-Myers Squibb, ipilimumab, melanoma
Biotech Exec Charged By SEC For Lying About Data
Pharmalot
Wednesday, June 2, 2010 - 5:19pm
tags:
SEC, Sequenom
Vaccination Rates For Merck’s Gardasil Are Low
Pharmalot
Wednesday, June 2, 2010 - 5:17pm
tags:
Merck, vaccines, HPV, Gardasil

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.